COST- EFFECTIVENESS OF PNEUMOCOCCAL VACCINATION FOR ADULTS AGED 60 YEARS AND OLDER IN PERU

被引：0
|
作者：
Figueroa, J. [1 ]
Owusu-Edusei, K. [2 ]
Valenzuela, G. [1 ]
Cossrow, N. [3 ]
Johnson, K. D. [3 ]
Parellada, C. [4 ]
机构：
[1] MSD Peru, Market Access, Lima, Peru
[2] Merck & Co Inc, Biostat Res Decis Sci BARDS, Rahway, NJ USA
[3] Merck & Co Inc, Ctr Observat & Real World Evidence, Rahway, NJ USA
[4] MSD Brazil, Ctr Observat & Realworld Evidence CORE Latin Amer, Sao Paulo, SP, Brazil
来源：
VALUE IN HEALTH | 2023年 / 26卷 / 12期
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
EE745
引用
收藏
页码：S198 / S198
页数：1
相关论文
共 50 条
  • [1] Cost-Effectiveness of Pneumococcal Vaccines for Adults Aged 65 Years and Older in Argentina
    Giglio, Norberto D.
    Castellano, Vanesa E.
    Mizrahi, Patricia
    Micone, Paula, V
    VALUE IN HEALTH REGIONAL ISSUES, 2022, 28 : 76 - 81
  • [2] COST-EFFECTIVENESS OF PNEUMOCOCCAL CONJUGATE VACCINATION STRATEGIES IN US ADULTS AGED 65 AND OLDER
    Smith, Kenneth J.
    Wateska, Angela
    Nowalk, Mary Patricia
    Raymund, Mahlon
    Zimmerman, Richard K.
    JOURNAL OF GENERAL INTERNAL MEDICINE, 2012, 27 : S150 - S150
  • [3] THE COST-EFFECTIVENESS OF PNEUMOCOCCAL VACCINATION IN TAIWAN OLDER ADULTS
    Kuo, K.
    Chen, U.
    Yang, C.
    Wu, Y.
    Gau, C.
    VALUE IN HEALTH, 2018, 21 : S67 - S67
  • [4] COST-EFFECTIVENESS ANALYSIS OF IMPROVED INFLUENZA VACCINATION COVERAGE IN ADULTS AGED 60 YEARS AND OLDER IN BEIJING, CHINA
    Cheng, X.
    Aballea, S.
    Dorey, J.
    Zhou, J.
    Jia, Y.
    Toumi, M.
    VALUE IN HEALTH, 2016, 19 (07) : A912 - A912
  • [5] Pneumococcal Vaccination in Adults Aged ≥65 Years: Cost-Effectiveness and Health Impact in US Populations
    Wateska, Angela R.
    Nowalk, Mary Patricia
    Lin, Chyongchiou J.
    Harrison, Lee H.
    Schaffner, William
    Zimmerman, Richard K.
    Smith, Kenneth J.
    AMERICAN JOURNAL OF PREVENTIVE MEDICINE, 2020, 58 (04) : 487 - 495
  • [6] Modeling of Cost Effectiveness of Pneumococcal Conjugate Vaccination Strategies in US Older Adults
    Smith, Kenneth J.
    Wateska, Angela R.
    Nowalk, Mary Patricia
    Raymund, Mahlon
    Lee, Bruce Y.
    Zimmerman, Richard K.
    AMERICAN JOURNAL OF PREVENTIVE MEDICINE, 2013, 44 (04) : 373 - 381
  • [7] COST-EFFECTIVENESS OF PNEUMOCOCCAL VACCINATION STRATEGIES IN OLDER ADULTS OF HONG KONG
    Li, X.
    Shami, J.
    Suh, I
    Chan, E. W.
    VALUE IN HEALTH, 2019, 22 : S200 - S200
  • [8] COST-EFFECTIVENESS OF 13-VALENT PNEUMOCOCCAL CONJUGATE VACCINE IN INDIAN ADULTS AGED ≥60 YEARS
    Kulkarni, N.
    Averin, A.
    Taur, S.
    Huang, L.
    Hariharan, D.
    Atwood, M.
    Gupta, N.
    VALUE IN HEALTH, 2023, 26 (12) : S136 - S136
  • [9] Cost-effectiveness of vaccination against herpes zoster in adults aged over 60 years in Belgium
    Bilcke, Joke
    Marais, Christiaan
    Ogunjimi, Benson
    Willem, Lander
    Hens, Niel
    Beutels, Philippe
    VACCINE, 2012, 30 (03) : 675 - 684
  • [10] Cost-effectiveness of pneumococcal vaccines among adults aged 65 years and older in China: A comparative study
    Guo, Jia
    Zhang, Haijun
    Zhang, Haonan
    Lai, Xiaozhen
    Wang, Jiahao
    Feng, Huangyufei
    Fang, Hai
    VACCINE, 2023, 41 (03) : 716 - 723
12345